BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34172003)

  • 41. Bloodstream infections caused by Escherichia coli producing AmpC β-lactamases: epidemiology and clinical features.
    Pascual V; Alonso N; Simó M; Ortiz G; Garcia MC; Xercavins M; Rivera A; Morera MA; Miró E; Espejo E; Navarro F; Gurguí M; Pérez J; Rodríguez-Carballeira M; Garau J; Calbo E
    Eur J Clin Microbiol Infect Dis; 2016 Dec; 35(12):1997-2003. PubMed ID: 27549108
    [TBL] [Abstract][Full Text] [Related]  

  • 42. External validation of bloodstream infection mortality risk score in a population-based cohort.
    Al-Hasan MN; Juhn YJ; Bang DW; Yang HJ; Baddour LM
    Clin Microbiol Infect; 2014 Sep; 20(9):886-91. PubMed ID: 25455590
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High Burden of Extended-Spectrum β-Lactamase-Producing
    Sawatwong P; Sapchookul P; Whistler T; Gregory CJ; Sangwichian O; Makprasert S; Jorakate P; Srisaengchai P; Thamthitiwat S; Promkong C; Nanvatthanachod P; Vanaporn M; Rhodes J
    Am J Trop Med Hyg; 2019 Apr; 100(4):943-951. PubMed ID: 30793684
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Attributable mortality and excess length of stay associated with third-generation cephalosporin-resistant Enterobacterales bloodstream infections: a prospective cohort study in Suva, Fiji.
    Loftus MJ; Young-Sharma TEMW; Lee SJ; Wati S; Badoordeen GZ; Blakeway LV; Byers SMH; Cheng AC; Cooper BS; Cottingham H; Jenney AWJ; Hawkey J; Macesic N; Naidu R; Prasad A; Prasad V; Tudravu L; Vakatawa T; van Gorp E; Wisniewski JA; Rafai E; Peleg AY; Stewardson AJ
    J Glob Antimicrob Resist; 2022 Sep; 30():286-293. PubMed ID: 35738385
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Burden of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third-generation cephalosporins.
    de Kraker ME; Wolkewitz M; Davey PG; Koller W; Berger J; Nagler J; Icket C; Kalenic S; Horvatic J; Seifert H; Kaasch A; Paniara O; Argyropoulou A; Bompola M; Smyth E; Skally M; Raglio A; Dumpis U; Melbarde Kelmere A; Borg M; Xuereb D; Ghita MC; Noble M; Kolman J; Grabljevec S; Turner D; Lansbury L; Grundmann H
    J Antimicrob Chemother; 2011 Feb; 66(2):398-407. PubMed ID: 21106563
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Risk factors and prognosis in 31 patients with extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae bloodstream infection].
    Chen YH; Yao WZ; Wu R; Zhou QT; Liu ZY; Zhang XW
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Nov; 31(11):815-9. PubMed ID: 19080534
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Escherichia coli bacteraemia in Canberra: incidence and clinical features.
    Kennedy KJ; Roberts JL; Collignon PJ
    Med J Aust; 2008 Feb; 188(4):209-13. PubMed ID: 18279126
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mortality and associated risk factors in consecutive patients admitted to a UK NHS trust with community acquired bacteraemia.
    Hounsom L; Grayson K; Melzer M
    Postgrad Med J; 2011 Nov; 87(1033):757-62. PubMed ID: 21798969
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of risk factors for the acquisition of bloodstream infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in the intensive care unit; antibiotic management and clinical outcome.
    Cordery RJ; Roberts CH; Cooper SJ; Bellinghan G; Shetty N
    J Hosp Infect; 2008 Feb; 68(2):108-15. PubMed ID: 18063198
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis of early-onset bloodstream infection due to Escherichia coli infection in premature babies.
    Chen IL; Huang HC; Wu CT; Ou-Yang MC; Chung MY; Chen CC; Suen JL; Hung CH
    Medicine (Baltimore); 2017 Aug; 96(32):e7748. PubMed ID: 28796061
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Age- and sex-associated trends in bloodstream infection: a population-based study in Olmsted County, Minnesota.
    Uslan DZ; Crane SJ; Steckelberg JM; Cockerill FR; St Sauver JL; Wilson WR; Baddour LM
    Arch Intern Med; 2007 Apr; 167(8):834-9. PubMed ID: 17452548
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of Sequence Type (ST) 131 in adult community-onset non-ESBL-producing Escherichia coli bacteraemia.
    Wu YH; Cheng MF; Lai CH; Lin HH; Hung CH; Wang JL
    BMC Infect Dis; 2014 Nov; 14():579. PubMed ID: 25377351
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A retrospective study on Escherichia coli bacteremia in immunocompromised patients: Microbiological features, clinical characteristics, and risk factors for shock and death.
    Tao X; Wang H; Min C; Yu T; Luo Y; Li J; Hu Y; Yan Q; Liu WE; Zou M
    J Clin Lab Anal; 2020 Aug; 34(8):e23319. PubMed ID: 32267010
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A multicentre analysis of epidemiology of the nosocomial bloodstream infections in Japanese university hospitals.
    Nagao M
    Clin Microbiol Infect; 2013 Sep; 19(9):852-8. PubMed ID: 23176224
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013.
    Johnson NB; Hayes LD; Brown K; Hoo EC; Ethier KA;
    MMWR Suppl; 2014 Oct; 63(4):3-27. PubMed ID: 25356673
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Bacteremia caused by Escherichia coli and Klebsiella pneumoniae producing extended-spectrum betalactamases: mortality and readmission-related factors].
    Perianes-Díaz ME; Novo-Veleiro I; Solís-Díaz K; Prolo-Acosta A; García-García I; Alonso-Claudio G
    Med Clin (Barc); 2014 May; 142(9):381-6. PubMed ID: 23735867
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence and outcome of bloodstream infections due to third-generation cephalosporin-resistant Enterobacteriaceae in sub-Saharan Africa: a systematic review.
    Lester R; Musicha P; van Ginneken N; Dramowski A; Hamer DH; Garner P; Feasey NA
    J Antimicrob Chemother; 2020 Mar; 75(3):492-507. PubMed ID: 31742611
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bacteraemia due to non-ESBL-producing Escherichia coli O25b:H4 sequence type 131: insights into risk factors, clinical features and outcomes.
    Morales-Barroso I; López-Cerero L; Molina J; Bellido M; Navarro MD; Serrano L; González-Galán V; Praena J; Pascual A; Rodríguez-Baño J
    Int J Antimicrob Agents; 2017 Apr; 49(4):498-502. PubMed ID: 28257756
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The outcome and timing of death of 17,767 nosocomial bloodstream infections in acute care hospitals in Finland during 1999-2014.
    Kontula KSK; Skogberg K; Ollgren J; Järvinen A; Lyytikäinen O
    Eur J Clin Microbiol Infect Dis; 2018 May; 37(5):945-952. PubMed ID: 29455272
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Incidence of and Risk Factors for Third-Generation Cephalosporin-Resistant
    Cheng J; Liu Y; Li S; Pu K; Yang L; Tan L
    Infect Drug Resist; 2024; 17():543-550. PubMed ID: 38352624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.